接纳与承诺疗法心理干预对原发性肝癌患者负性情绪和治疗依从性的影响

肝癌电子杂志 ›› 2024, Vol. 11 ›› Issue (1): 38-41.

接纳与承诺疗法心理干预对原发性肝癌患者负性情绪和治疗依从性的影响

孙亚莉, 同欢庆^*, 袁泼棉, 刘乐, 吴娜, 周侃, 翟九玲

咸阳市中心医院肝胆外科,陕西咸阳 712000

收稿日期:2022-03-07 出版日期:2024-03-31 发布日期:2024-05-08
通讯作者: ^*同欢庆,E-mail：664024894@qq.com

The effects of acceptance and commitment therapy psychological intervention on negative emotion and treatment compliance of patients with primary liver cancer

Sun Yali, Tong Huanqing^*, Yuan Pomian, Liu Le, Wu Na, Zhou Kan, Zhai Jiuling

Department of Hepatobiliary Surgery, Xianyang Central Hospital, Xianyang 712000, Shaanxi, China

Received:2022-03-07 Online:2024-03-31 Published:2024-05-08
Contact: ^*Tong Huanqing, E-mail: 664024894@qq.com

摘要/Abstract

摘要： 目的: 探讨接纳与承诺疗法（acceptance and commitment therapy,ACT）心理干预对原发性肝癌患者负性情绪和治疗依从性的影响。
方法: 选取2019年5月至2021年4月咸阳市中心医院收治的100例原发性肝癌患者进行前瞻性研究。按照入院时间顺序编号采用随机数字表法将100例患者分为干预组和对照组各50例。对照组患者给予常规心理护理,干预组患者在常规心理护理基础上实施ACT心理干预。比较两组患者治疗依从性,以及护理后抑郁自评量表（depression self-evaluation schedule,SDS）、焦虑自评量表（anxiety and self-evaluation scale,SAS）评分。
结果: 干预组患者治疗依从性高于对照组患者[96.0%（48/50）比78.0%（39/50）],且差异有统计学意义（χ²=5.315,P<0.05）。护理后干预组患者SDS评分、SAS评分均低于对照组患者[（49.3±1.7）分比（53.0±1.6）分,（44.2±1.5）分比（48.9±1.5）分],且差异均有统计学意义（t=11.525、15.969,P均<0.001）。
结论: 应用ACT进行心理干预,可减少原发性肝癌患者负性情绪,提高其治疗依从性,改善患者心理压力,从而提高患者的生活质量。

关键词: 接纳与承诺疗法, 原发性肝癌, 负性情绪, 治疗依从性

Abstract: Objective: To investigate the effects of acceptance and commitment therapy (ACT) psychological intervention on negative emotion and treatment compliance of patients with primary liver cancer.
Method: Totally 100 patients were choose with primary liver cancer in our department for the observation object from May 2019 to April 2021. According to the admission time order using a random digital table to divide the patient into 50 cases of intervention group and control group. And the control group were given conventional care, intervention group implements ACT psychological intervention on the basis of regular care. Compared the results of the two groups.
Result: Anxiety and self-evaluation scale (SAS) rating / depression self-evaluation schedule (SDS) score of the intervention group is lower than that of the control group [96.0%(48/50) vs 78.0%(39/50), χ²=5.315, P<0.05]. The treatment compliance of the intervention group was higher than that of the control group [(49.3±1.7) vs (53.0±1.6), t=11.525, P<0.001; (44.2±1.5) vs (48.9±1.5), t=15.969,P<0.001].
Conclusion: Application of ACT psychological intervention, can reduce negative emotion of patients with primary liver cancer to improve their treatment compliance, reduce patient psychological pressure, thereby improving the survival quality of patients.

Key words: Acceptance and commitment therapy, Primary liver cancer, Negative emotion, Treatment compliance

孙亚莉, 同欢庆, 袁泼棉, 刘乐, 吴娜, 周侃, 翟九玲. 接纳与承诺疗法心理干预对原发性肝癌患者负性情绪和治疗依从性的影响[J]. 肝癌电子杂志, 2024, 11(1): 38-41.

Sun Yali, Tong Huanqing, Yuan Pomian, Liu Le, Wu Na, Zhou Kan, Zhai Jiuling. The effects of acceptance and commitment therapy psychological intervention on negative emotion and treatment compliance of patients with primary liver cancer[J]. Electronic Journal of Liver Tumor, 2024, 11(1): 38-41.

参考文献

[1] VILLANUEVA A.Hepatocellular carcinoma[J]. N Eng IJ Med, 2019, 380(15): 1450-1462.
[2] ZHOU M, WANG H, ZENG X, et al.Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017[J]. Lancet, 2019, 394(10204): 1145-1158.
[3] SUNG H, FERLAY J, SIEGEL R L, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[4] 沈君霞, 余灵安, 沈丹, 等. 认知行为疗法对肝癌晚期并发抑郁患者心理健康的影响[J]. 护士进修杂志, 2016, 31(11): 975-977.
[5] 任丽华, 钟敏, 郭素萍. ACT心理干预对肺癌放疗患者癌因性疲乏/疾病感知控制及生活质量的影响[J]. 齐鲁护理杂志, 2021, 27(9): 110-112.
[6] 贾晓利, 宋婷, 申聿伟. 以接纳与承诺疗法为基础的延续干预对甲状腺癌术后患者的影响[J]. 医学理论与实践, 2023, 36(12): 2139-2142.
[7] GANESAN P, KULIK L M.Hepatocellular carcinoma: new developments[J]. Clin Liver Dis, 2023, 27(1): 85-102.
[8] INCE V, SAHIN T T, AKBULUT S, et al.Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria[J]. World J Clin Cases, 2022, 10(29): 10413-10427.
[9] QIN S, REN Z, MENG Z, et al.Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial[J]. Lancet Oncol, 2020, 21(4): 571-580.
[10] MAKKER V, RASCO D, VOGELZANG N J, et al.Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single arm, phase 2 trial[J]. Lancet Oncol, 2019, 20(5): 711-718.
[11] CHAN S L, CHONG C C, CHAN A W, et al.Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016[J]. World J Gastroenterol, 2016, 22(32): 7289-7300.
[12] 冀小飞, 袁学科, 刘名君. 基于接纳承诺疗法的护理干预对结直肠癌造口病人病耻感的影响[J]. 全科护理, 2021, 19(30): 4269-4272.
[13] 任爱娜, 张海强, 王惠儿, 等. 接纳与承诺疗法在肿瘤患者疼痛管理中的应用研究[J]. 护理与康复, 2021, 20(8): 50-53.
[14] 周赟洁, 刘艳梅, 卢丹丹. 接纳与承诺疗法在周围性面瘫病人中的应用[J]. 蚌埠医学院学报, 2023, 48(5): 669-672 .
[15] 毛燕萍. 接纳与承诺疗法对初治肺结核患者情绪状态及服药依从性的影响[J]. 当代护士, 2023, 30(15): 96-99.
[16] 汪冰心, 张苇, 陈晓娟, 等. 接纳与承诺疗法对永久性肠造口患者造口接受度和社会心理适应的影响[J]. 护理学报, 2021, 28(20): 68-73.
[17] 庄雪珍, 朱纯. 接纳与承诺疗法在腰椎间盘突出症患者中的应用研究[J]. 护理管理杂志, 2021, 21(11): 825-828.